HealthEquity (HQY)
(Delayed Data from NSDQ)
$79.56 USD
+2.47 (3.20%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $79.51 -0.05 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$79.56 USD
+2.47 (3.20%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $79.51 -0.05 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Zacks News
Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HQY) Outperforming Other Medical Stocks This Year?
HealthEquity (HQY) Down 3.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Leads Telehealth Thanks to its Virtual Care Solution
by Zacks Equity Research
Teladoc's (TDOC) vast product portfolio, client base, tie-ups and acquisitions make it a leader in the telehealth industry.
Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HQY) Outperforming Other Medical Stocks This Year?
Here's Why Momentum Investors Will Love HealthEquity (HQY)
by Zacks Equity Research
Does HealthEquity (HQY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Looking for a Growth Stock? Why It is Time to Focus on HealthEquity (HQY)
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).
HealthEquity (HQY) Beats Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Strong HSA Member growth boosts HealthEquity's (HQY) results in Q2. A strong guidance raises investors??? optimism.
Can HSA Member Growth Drive HealthEquity's (HQY) Q2 Earnings?
by Zacks Equity Research
HealthEquity (HQY) is likely to register solid HSA member growth in the quarter to be reported.
HealthEquity (HQY) Q2 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SYNH or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYNH vs. HQY: Which Stock Is the Better Value Option?
CIVI or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CIVI vs. HQY: Which Stock Is the Better Value Option?
SYNH vs. HQY: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYNH vs. HQY: Which Stock Is the Better Value Option?
NovoCure Limited (NVCR) Looks Good: Stock Adds 7.9% in Session
by Zacks Equity Research
NovoCure (NVCR) was a big mover last session, as the company saw its shares rise more than 7% on the day amid huge volumes.
Is HealthEquity (HQY) a Great Growth Stock?
by Zacks Equity Research
HealthEquity (HQY) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
Can HealthEquity (HQY) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
HealthEquity (HQY) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision in addition to having decent short-term momentum.
HealthEquity (HQY) Looks Good: Stock Adds 11.5% in Session
by Zacks Equity Research
HealthEquity (HQY) was a big mover last session, as the company saw its shares rise more than 11% on the day amid huge volumes.
Medical Stocks Reporting Q4 Earnings on Feb 6: CNC, WCG, HQY
by Zacks Equity Research
Medical stocks' fourth-quarter results are likely to benefit from higher membership, increase in premium, partly offset by high costs.
Should You Buy HealthEquity (HQY) Ahead of Earnings?
by Zacks Equity Research
HealthEquity (HQY) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Looking for a Growth Stock? Why It is Time to Focus on HealthEquity (HQY)
by Zacks Equity Research
HealthEquity (HQY) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
ICON Public Limited (ICLR) Rises: Stock Adds 6.3% in Session
by Zacks Equity Research
ICON Public Limited Company (ICLR) shares rose over 6% in the last trading session.
Why HealthEquity (HQY) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).
HealthEquity (HQY) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity Inc (HQY) reported earnings of 7 cents per share in the fourth quarter of 2016, higher than the Zacks Consensus Estimate of 5 cents.
Top 5 Medical Service Stocks to Buy
by Brian Hamilton
The Medical sector is one of the top performing sectors for Q3 2015, and it is expected to be a top performer in Q4 2015 too.